19 results
8-K
EX-10.1
GOSS
Gossamer Bio Inc
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
and federal environmental Laws (including Laws relating to the use, disposal or release of hazardous or toxic substances or relating to the protection … or restoration of the environment or human exposure to hazardous or toxic substances), and all applicable Laws enforced by the United States Food and Drug
8-K
EX-1.1
GOSS
Gossamer Bio Inc
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum
8-K
EX-1.2
t6kg1
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-10.1
dh4918elznf1s
3 May 19
Gossamer Bio Secures Debt Facility for Up to $150 Million
4:00pm
10-K
pw5zs4xgyhppnhpz2u
22 Mar 19
Annual report
4:45pm
424B4
d2i41ldw m4gg0
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
EX-1.1
fpnh 9va9ayhdx
23 Jan 19
IPO registration (amended)
4:39pm
S-1/A
tfbwp slkp
23 Jan 19
IPO registration (amended)
4:39pm
S-1
rj5hfuxuesihgg4 47t9
21 Dec 18
IPO registration
4:39pm
S-1
EX-10.15
126xesxddi8rd xlw
21 Dec 18
IPO registration
4:39pm
DRS/A
85c0dg
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
EX-10.11
88ilbxk srlinfiv3zr
11 Oct 18
Draft registration statement
12:00am
DRS
d9cd2
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next